deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04176965

Investigation of the Safety and Effectiveness of a Trifocal IOL

Clinical Investigation of the Safety and Effectiveness of FINEVISION HP Trifocal IOL

Sponsor: Beaver-Visitec International, Inc.

Conditions Cataract Eye Diseases Lens Opacities Postcataract Aphakia
Interventions Alcon AcrySof SN60AT FINEVISION HP IOL
Updated 18 times since 2019 Last updated: Jan 3, 2025 Started: Apr 28, 2022 Primary completion: May 13, 2024 Completion: May 13, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04176965, this NA trial focuses on Cataract and Eye Diseases and remains completed. Sponsored by Beaver-Visitec International, Inc., it has been updated 18 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Aug 2020 · 7 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~May 2023 · 4 months · monthly snapshot~May 2023 – ~Oct 2023 · 5 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Feb 2025 — Sep 2025 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  3. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: Withheld → Active Not Recruiting · Phase: None → NA

▶ Show 13 earlier versions

  1. May 2023 — Oct 2023 [monthly]

    Withheld

  2. Jan 2023 — May 2023 [monthly]

    Withheld

  3. Dec 2022 — Jan 2023 [monthly]

    Withheld

  4. Sep 2022 — Dec 2022 [monthly]

    Withheld

  5. Jul 2022 — Sep 2022 [monthly]

    Withheld

  6. May 2022 — Jul 2022 [monthly]

    Withheld

  7. Mar 2022 — May 2022 [monthly]

    Withheld

  8. Dec 2021 — Mar 2022 [monthly]

    Withheld

  9. Jun 2021 — Dec 2021 [monthly]

    Withheld

  10. Jan 2021 — Jun 2021 [monthly]

    Withheld

  11. Aug 2020 — Jan 2021 [monthly]

    Withheld

  12. Jan 2020 — Aug 2020 [monthly]

    Withheld

    Status: Not Yet Recruiting → Withheld · Phase: NA → None

  13. Dec 2019 — Jan 2020 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beaver-Visitec International, Inc.
Data source: Beaver-Visitec International, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alexandria, United States , Bloomington, United States , Bozeman, United States , Brecksville, United States , Dallas, United States , Indianapolis, United States , Las Vegas, United States , Lynchburg, United States , Nacogdoches, United States , Northridge, United States and 10 more locations